Risk factors for relapse in children with Hodgkin lymphoma treated with chemotherapy alone protocols

Risk factors for relapse in children with Hodgkin lymphoma treated with chemotherapy alone protocols

Bibliographic Details
Main Authors:	Vineeta Gupta, Rimjhim Sonowal, Tej Bali Singh, Sanjeev Kumar Gupta
Format:	Article
Language:	English
Published:	Elsevier 2017-01-01
Series:	Pediatric Hematology Oncology Journal
Online Access:	http://www.sciencedirect.com/science/article/pii/S2468124517301997

Similar Items

Role of cardiac biomarkers in detection of myocardial damage in children with hematological malignancies treated with anthracyclines
by: Sunil Kumar Singh, et al.
Published: (2016-01-01)

Treatment of Relapsed and Refractory Hodgkin’s Lymphoma in Children
by: NS Kulichkina, et al.
Published: (2016-01-01)

Outcomes and relapse patterns following chemotherapy in advanced Hodgkin lymphoma in the positron emission tomography era
by: Lapuz C, et al.
Published: (2018-04-01)

Study of bone mineral metabolism in children with acute lymphoblastic leukemia
by: Shalini Dash, et al.
Published: (2017-01-01)

Obstructive jaundice as manifestation of relapsing Hodgkin’s Lymphoma: the success of chemotherapy (case report)
by: Fauzi Yusuf, et al.
Published: (2020-04-01)

Salvage therapy for refractory high-risk Langerhans Cell Histiocytosis – A case report
by: Shalini Dash, et al.
Published: (2016-01-01)

TREATMENT OF RELAPSE AND REFRACTORY HODGKIN LYMPHOMA
by: E. A. Baryakh
Published: (2017-06-01)

Testicular Involvement in Relapsed Hodgkin Lymphoma
by: Sinan Demircioğlu, et al.
Published: (2016-10-01)

Hodgkin Lymphoma : Studies of Advanced Stages, Relapses and the Relation to Non-Hodgkin Lymphomas
by: Amini, Rose-Marie
Published: (2002)

Outcomes of Elderly Patients with Non-Hodgkin's Lymphoma Treated with Chemotherapy
by: YingFen Hsia, et al.
Published: (2001)

Early Radiation-Induced Sarcoma in an Adolescent Treated for Relapsed Hodgkin Lymphoma with Nivolumab
by: Lukas Šalaševičius, et al.
Published: (2020-03-01)

Nursing management of patients with relapsed or refractory classical Hodgkin's lymphoma treated with sintilimab
by: KUANG Meiling
Published: (2021-01-01)

Relapsed and refractory classical Hodgkin lymphoma immunotherapy
by: Kirill Lepik
Published: (2020-10-01)

Non-Hodgkin lymphoma with relapses in the lacrimal glands
by: Couceiro, Rita, et al.
Published: (2015-06-01)

Mediastinal Choriocarcinoma Masquerading as Relapsed Hodgkin Lymphoma
by: Selay Lam, et al.
Published: (2011-10-01)

New agents in relapsed/refractory Hodgkin's lymphoma
by: Irene Biasoli, et al.

Effectiveness of chemotherapy after anti‐PD‐1 blockade failure for relapsed and refractory Hodgkin lymphoma
by: Beatrice Casadei, et al.
Published: (2020-11-01)

Primary Non-Hodgkin's Malignant Lymphoma of the Sinonasal Tract
by: Nitin Gupta, et al.
Published: (2009-09-01)

Profile of renal diseases in North-East Indian children
by: Rimjhim Sonowal
Published: (2019-01-01)

Clinical Outcome of Primary Gastric Lymphoma Treated with Chemotherapy Alone or Surgery Followed by Chemotherapy
by: Ming-Chih Chang, et al.
Published: (2006-01-01)

Therapeutic Updates for Relapsed and Refractory Classical Hodgkin Lymphoma
by: Timothy J Voorhees, et al.
Published: (2020-10-01)

Paraspinal mass as a presentation in relapsed Hodgkin lymphoma
by: Vikas Dua, et al.
Published: (2013-01-01)

Brentuximab vedotin for relapsed or refractory Hodgkin’s lymphoma
by: Chen R, et al.
Published: (2015-03-01)

Outcome of Very Late Relapse in Patients with Hodgkin's Lymphomas
by: Francesco Gaudio, et al.
Published: (2011-01-01)

Hodgkin′s lymphoma presenting as chylothorax
by: Sanjeev Kumar Verma, et al.
Published: (2014-01-01)

Health of children born to women after radiation and chemotherapy for Hodgkin's lymphoma
by: A. A. Danilenko, et al.
Published: (2014-09-01)

Health of children born to women after radiation and chemotherapy for Hodgkin's lymphoma
by: A. A. Danilenko, et al.
Published: (2014-09-01)

Sarcoid Reactions after Chemotherapy for Hodgkin's Lymphoma
by: Baldeep Wirk
Published: (2010-01-01)

Proteomic Profiles and Biological Processes of Relapsed vs. Non-Relapsed Pediatric Hodgkin Lymphoma
by: Ombretta Repetto, et al.
Published: (2020-03-01)

Clinical Profile and Chemotherapy Response in Children with Hodgkin Lymphoma at a Tertiary Care Centre
by: Rachna Seth, et al.
Published: (2015-11-01)

Generalized granuloma annulare heralding relapse of non-Hodgkin lymphoma
by: Sarah A. King, MEng, et al.
Published: (2020-06-01)

Brentuximab vedotin in the treatment of relapsed and refractory forms of Hodgkin lymphoma
by: E A Demina
Published: (2016-06-01)

Dual Immunotherapy Adds Value in Relapsed/Refractory Hodgkin Lymphoma
by: Simon Hallam
Published: (2018-08-01)

Clinical Options in Relapsed or Refractory Hodgkin Lymphoma: An Updated Review
by: Roberta Fedele, et al.
Published: (2015-01-01)

Intravitreal rituximab for the treatment of intraocular relapse of non-Hodgkin’s lymphoma
by: Eva Fernández Cañabate, et al.
Published: (2018-01-01)

Role of brentuximab vedotin in the treatment of relapsed or refractory Hodgkin lymphoma
by: Siddiqi T, et al.
Published: (2014-02-01)

A case of metachronous peripheral T‐Cell non‐Hodgkin lymphoma following chemotherapy for Hodgkin disease successfully treated with brentuximab vedotin
by: Federico Meconi, et al.
Published: (2020-08-01)

Neutropenia and Neutropenic Complications in ABVD Chemotherapy for Hodgkin Lymphoma
by: Bhanu Vakkalanka, et al.
Published: (2011-01-01)

Evaluating the Survival Rate and the Secondary Malignancies after Treating Hodgkin's Lymphoma Patients with Chemotherapy Regimens
by: Ahmad Ahmadzadeh, et al.
Published: (2014-06-01)

Circulating tumor DNA predicts response in Chinese patients with relapsed or refractory classical hodgkin lymphoma treated with sintilimab
by: Yuankai Shi, et al.
Published: (2020-04-01)

Cannot write session to /tmp/vufind_sessions/sess_a33ukl7l7mbd9jni78jt01mcon